The British medical journal Lancet published a study at the University of Oxford on the 21st day aspirin tablets can effectively reduce the incidence of many types of cancer and cancer treatment.

The study showed that aspirin can prevent cancer cells and platelet binding, thereby blocking the cancer cells spread, have played a certain effect in the treatment of colorectal, breast and other common types of cancer.

Research team under the leadership of Professor Peter Roswell, the object of more than 70,000 randomly selected 51 groups of tests and found that daily aspirin for cancer patients than in patients with cancer do not take the spread of the probability of 1/3, it was diagnosed in patients with the cancer cells will be substantially the spread of cancer cell proliferation rate in the aspirin only half of the expected.